Service Communautaire d'Information sur la Recherche et le Développement - CORDIS

FP6

CELLAID Résumé de rapport

Project ID: 5094
Financé au titre de: FP6-LIFESCIHEALTH
Pays: Germany

Final Report Summary - CELLAID (European symposia for the evaluation of potentials and perspectives of curative cell therapies for autoimmune diseases)

The ultimate aim of the CELLAID project was to enhance the development of concepts of curative specific therapies and translate them into clinical applications. Its specific objectives were to:
- arrange European symposia on cell-based therapies for autoimmune diseases;
- create an integrated communication platform for European experts;
- foster European research institute networks to enhance standardisation of clinical interventions and quality assessment;
- evaluate the European potential and perspectives;
- affect political processes with the aim of improving the awareness and priority of rheumatic diseases within the European Union (EU)

Three symposia on cell-based therapies were set up to examine cell therapy approaches for treatment of autoimmune diseases. The sessions covered epidemiology, basic and translational science, as well as the patient's expectations. Discussions of research data led to the development of new therapeutic strategies and innovative concepts towards clinical applications. By providing a communication platform, a network of leading European research institutions was established. The CELLAID initiative published recommendations to improve the awareness and priority of rheumatic diseases within the EU and to define and suggest research priorities for the Seventh Framework Programme (FP7).

Informations connexes

Contact

Jutta STEINKÖTTER, (Research Coordinator)
Tél.: +49-3024048474
Fax: +49-3024048479
E-mail